 |
BioWorld-International-2011-04-13
Mysterious Serum Factor Linked to Poor Sleep in the Elderly
Pieris, Daiichi Sankyo Ink Anticalins Deal for up to $296M
Pieris AG is banking €7 million (US$10.1 million) up front and could earn up to €200 million more in milestone payments and research funding from a discovery deal with Daiichi Sankyo, based around its anticalin protein scaffold technology. (BioWorld International)